Financial Year |
March 31 2023 |
Monetary Funds |
322,096,437.59 |
Held-for-trading Financial Assets |
13,858,600.00 |
Notes Receivable |
37,723,199.56 |
Accounts Receivable |
348,268,803.57 |
Advances to Suppliers |
2,394,951.24 |
Other Receivables |
2,800,614.32 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
407,522,371.39 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
73,760,123.10 |
Other Current Assets |
5,734,510.60 |
Total Current Assets |
1,214,159,611.37 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
44,405,629.24 |
Long-term Equity Investment |
63,225,903.85 |
Investment Properties |
1,268,762.90 |
Fixed Assetes |
151,388,028.10 |
Under-construction Projects |
84,568,601.79 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
15,806,223.90 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
7,499,040.33 |
Deferred Income Tax Assets |
11,223,588.34 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
504,559,300.49 |
Total Assets |
1,718,718,911.86 |
Short-Term Loans |
214,409,600.00 |
Trading Financial liabilities |
-- |
Notes Payable |
46,521,474.52 |
Accounts Payable |
65,120,970.44 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
33,350,168.15 |
Taxes Payable |
12,304,386.93 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
17,318,027.80 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
403,421.31 |
Other Current Liabilities |
2,247,776.72 |
Sub-Total of Current Liabilities |
409,089,057.54 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
7,185,581.27 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
8,016,346.25 |
Total Liabilities |
417,105,403.79 |
Paid-In Capital(Or Share Stock) |
228,720,888.00 |
Capital Surplus |
607,578,751.51 |
Surplus Reserve |
52,052,726.13 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
412,943,678.70 |
Minority Stockholder's Interest |
294,116.26 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,301,319,391.81 |
Owner's Equity(Stockholder's Equity) |
1,301,613,508.07 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,718,718,911.86 |